Hemex

What they do

As a swiss investment and consulting company headquartered close to the Basel global life sciences hub, our main focus is to bring innovative drugs, medical devices and in vitro diagnostics to the market. We specialize in supporting start-ups. Working closely with your management team, we offer tailored solutions to accelerate your project into a successful and sustainable business. Our team of life science, legal and financial professionals covers a wide range of expertise. From development support like preclinical/clinical trial management, regulatory affairs, quality assurance, CMC and medical affairs, to business coaching, marketing strategy, intellectual property creating and finding financing solutions, we know how to successfully bring a product from the lab to the market. Our offices in Switzerland, Germany and USA work closely with local health authorities, patient groups, contract research organizations and key opinion leaders.

What they look for

Hemex focuses entirely on regulated healthcare products and technologies. Their thesis is built on the "smart money" concept: combining early-stage funding with hands-on guidance in clinical operations, regulatory affairs, and quality management to accelerate time-to-market. They look for innovative pharmaceuticals, biotech, medical devices (MedTech), and in-vitro diagnostics (IVD), with a preference for companies at Series A onwards, though they frequently enter at Seed. Key requirements include dedicated and competent founders, clear intellectual property, and business models that generate sustainable value with a clear path to exit or profitability.

Stage

Seed, Series A, Series B+

Sectors

Healthcare

Based

Liestal, CH